About this trial
We aim to determine the function of Right ventricle post mitral valve surgeries in patients with pulmonary hypertension using transthoracic echocardiography3- and 6-months post-operatively to detect the effect of mitral valve surgeries over the RV function whether improving, deteriorating, or not changing at all.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who underwent mitral valve surgeries who also had pulmonary hypertension in the period between March 2019 and March 2022 in Assiut university heart hospital
Disqualifiers
Patients who underwent mitral valve surgeries with normal pulmonary pressure. Patients who had other valve surgeries besides mitral as aortic and/or tricuspid valve surgeries. Patients had mitral valve surgeries with other heart conditions that needed another intervention in the same session as CABG for IHD.
Trial population
Descriptive cross-sectional
Trial design
Case-control
Retrospective
Treatments tested in this trial
Echocardiography
DeviceEchocardiography 3 and 6 months post operative
Treatment groups
Trial outcomes
Primary outcomes
Right Ventricular function post mitral valve surgeries in patients with pulmonary hypertension
to detect right ventricular function (ejection fraction percentage and/or TAPSE) through transthoracic echocardiography 3- and 6-months post operatively in patients who had mitral valve surgeries with pulmonary hypertension.
Secondary outcomes
Best mitral valve surgical modalities in patients with pulmonary hypertension
to identify best surgical modalities for mitral valve diseased patients with pulmonary hypertension that lead to improvement of right ventricle function.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: